Hypoalphalipoproteinemia Clinical Trial
Official title:
Effect of Tomato Consumption on Serum High Density Lipoprotein-cholesterol Levels. A Randomized, Open-label, Single Blind, Clinical Trial
- This is a randomized, open-label, single blind, clinical trial
- The study evaluated the effect of tomato consumption in serum HDL-cholesterol levels.
- The hypothesis was that two daily tomatoes during one month will increase the HDL-c
levels.
- Since a placebo of tomatoes cannot be done, the control group will receive same
proportion of cucumber because 1) it was not possible to have a tomato placebo; 2)
cucumber does not have any lycopene; 3) both can be prepared similarly; and 4) the
required quantity can be measured in the same way.
- The intervention was during 1 month and was assigned by randomization.
- Personnel who did the clinical and biochemical evaluation were blinded for the
intervention.
- Lipid profile was measured before and after the intervention.
- Confounding factors such as daily physical activity, diet, consumption of fish or
alcoholic beverages, smoking status were considered during statistical analyses.
Status | Completed |
Enrollment | 50 |
Est. completion date | December 2011 |
Est. primary completion date | April 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Males with HDL-c less than 40 mg/dl - Females with HDL-c less than 50 mg/dl - Age between 18 to 65 years old - Acceptance for participation with signed informed consent Exclusion Criteria: Previous diagnosis of: - Diabetes, - Hypertension, - Kidney, liver or heart insufficiency, - Hyperuricemia, - Hyperandrogenic anovulation, - Thyroid dysfunction (hypo or hyperthyroidism), - Any difficulty to swallow appropriately, or - Hospitalization in the previous six months. Additionally, those subjects under current treatment with fibrates, statins, nicotinic acid, steroids, allopurinol, hormone replacement therapy (testosterone, estrogens or progesterone), metformin, other oral hypoglycemic agents, insulin, sibutramine, or orlistat treatment and those with daily consumption of any non-steroidal anti-inflammatory drug were also excluded. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Mexico | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Mexico | Tlalpan |
Lead Sponsor | Collaborator |
---|---|
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Instituto Nacional de Cardiologia Ignacio Chavez |
Mexico,
Agarwal S, Rao AV. Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids. 1998 Oct;33(10):981-4. — View Citation
Ali MM, Agha FG. Amelioration of streptozotocin-induced diabetes mellitus, oxidative stress and dyslipidemia in rats by tomato extract lycopene. Scand J Clin Lab Invest. 2009;69(3):371-9. doi: 10.1080/00365510802658473. — View Citation
Arab L, Steck S. Lycopene and cardiovascular disease. Am J Clin Nutr. 2000 Jun;71(6 Suppl):1691S-5S; discussion 1696S-7S. Review. — View Citation
Ashen MD, Blumenthal RS. Clinical practice. Low HDL cholesterol levels. N Engl J Med. 2005 Sep 22;353(12):1252-60. Review. Erratum in: N Engl J Med. 2006 Jan 12;354(2):215. — View Citation
Blum A, Merei M, Karem A, Blum N, Ben-Arzi S, Wirsansky I, Khazim K. Effects of tomatoes on the lipid profile. Clin Invest Med. 2006 Oct;29(5):298-300. — View Citation
Denniss SG, Haffner TD, Kroetsch JT, Davidson SR, Rush JW, Hughson RL. Effect of short-term lycopene supplementation and postprandial dyslipidemia on plasma antioxidants and biomarkers of endothelial health in young, healthy individuals. Vasc Health Risk Manag. 2008;4(1):213-22. — View Citation
Fuhrman B, Elis A, Aviram M. Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun. 1997 Apr 28;233(3):658-62. — View Citation
Gianetti J, Pedrinelli R, Petrucci R, Lazzerini G, De Caterina M, Bellomo G, De Caterina R. Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis. Am Heart J. 2002 Mar;143(3):467-74. — View Citation
Kohlmeier L, Kark JD, Gomez-Gracia E, Martin BC, Steck SE, Kardinaal AF, Ringstad J, Thamm M, Masaev V, Riemersma R, Martin-Moreno JM, Huttunen JK, Kok FJ. Lycopene and myocardial infarction risk in the EURAMIC Study. Am J Epidemiol. 1997 Oct 15;146(8):618-26. — View Citation
Re R, Mishra GD, Thane CW, Bates CJ. Tomato consumption and plasma lycopene concentration in people aged 65 y and over in a British national survey. Eur J Clin Nutr. 2003 Dec;57(12):1545-54. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | High Density Lipoprotein Cholesterol (HDL-c) | To evaluate the effect of two daily tomatoes consumption on HDL-c levels. | Baseline and after one month | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01942291 -
Short-term Effect of Extended-release Niacin on Endothelial Function.
|
Phase 4 |